Artemis Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Artemis Wealth Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 21, 2023	BUY	$0.13 - $76.84 $0 - $537	7 New	7 $0
Q2 2022 Aug 21, 2023	BUY	$72.62 - $79.98 $508 - $559	7 New	7 $0
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $508 - $559	7 New	7 $1,000
Q4 2020 Feb 17, 2023	SELL	$57.74 - $65.43 $20,209 - $22,900	-350 Closed	0 $0
Q1 2020 Sep 05, 2023	BUY	$46.4 - $67.43 $16,240 - $23,600	350 New	350 $19,000
Q1 2020 Feb 17, 2023	BUY	$46.4 - $67.43 $15,915 - $23,128	343 Added 4900.0%	350 $20,000
Q1 2019 Sep 01, 2023	BUY	$45.12 - $53.8 $15,792 - $18,830	350 New	350 $16,000
Q1 2019 Feb 13, 2023	BUY	$45.12 - $53.8 $15,476 - $18,453	343 Added 4900.0%	350 $17,000
Q4 2018 Feb 09, 2023	BUY	$48.76 - $63.23 $16,724 - $21,687	343 Added 4900.0%	350 $18,000
Q1 2018 Aug 29, 2023	BUY	$59.92 - $68.98 $20,972 - $24,143	350 New	350 $22.1 Million
Q2 2017 Aug 29, 2023	BUY	N/A	350 New	350 $19.5 Million
Q1 2017 Aug 29, 2023	BUY	N/A	350 New	350 $0
Q4 2016 Feb 09, 2023	BUY	N/A	343	350 $20,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.